Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.
Issue link: http://gen.epubxp.com/i/729777
48 | OCTOBER 1, 2016 | GENengnews.com | Genetic Engineering & Biotechnology News CORPORATE CAPABILITIES Advertorial Bio-Techne Inc. 614 McKinley Place NE Minneapolis, MN 55413 Phone (612) 379 2956 Website www.bio-techne.com Founded 1976 Number of Employees 1,500 worldwide Bio-Techne B io-Techne, Minnesota's largest biotech company, makes products for medical research and drug development, and dis- tributes more than 200,000 products. In 2014, R&D; Systems, Novus Biologicals, Tocris, ProteinSimple, BiosPacific, Cliniqa, and RNA Medical were brought together under the um- brella of Bio-Techne to create a one-stop-shop for scientific researchers. Our products enable life science research in industrial and academic settings, and we count among our customers leading pharmaceutical companies and univer- sity researchers. The expertise at Bio-Techne includes three operat- ing divisions: Biotech, Protein Platforms, and Clinical Diagnostics. An industry leading segment of our business is developing and man- ufacturing purified pro- teins sold to biomedical researchers and clinical research labs and these are used aiding in drug discovery efforts and providing the means for accurate clinical tests and diagnoses. Quality is the driving force of the com- pany and a benchmark against which others are measured. It starts with leading quality control/product development, goes through manufacturing, then to final testing and pack- aging—all within the controlled settings of the Bio-Techne facility. Bio-Techne has a rich history in both research and diagnostics in the life sciences through its flagship brand R&D; Systems. The recent inte- gration of Novus Biologicals and Tocris Biosci- ence has respectively added a massive number of new antibodies and an extensive panel of small molecules and peptides that further drive bio- medical research and discovery. With the addi- tion of ProteinSimple platforms, we are extend- ing our immunoassay capabilities that simplify and speed laboratory workflow with next-gen- eration systems and consumables. Our goal is to automate protein analysis, and make it more accurate, quantitative, faster, and cost effec- tive. Collaborations and product synergies that have resulted from our cross-division relation- ships have exceeded expectations, and promise to bring more innovative solutions to drive your research for years to come. New Products for Cancer Research Immunotherapy has become an extremely promising approach for the treatment of can- cer. Immune checkpoint blockade, adoptive cell transfer, and targeting the tumor microenviron- ment are three approaches to harnessing the immune system to fight cancer. Bio-Techne life science brands offer the highest-quality proteins, validated antibodies, ELISAs, Luminex ® * as- says, small molecules, and cutting-edge instru- ments that you need to facilitate your research. Customer Support Is Paramount We employ the most knowledgeable and engaging technical and customer service rep- resentatives in the industry. By adhering to the highest quality standards at every level of the company and every stage of product develop- ment, through our outstanding customer and technical support, we deliver the best reagents and services that make your research stand out. Our experienced technical service representa- tives will resolve product performance issues by listening carefully, troubleshooting, and provid- ing detailed technical guidance. The Bio-Techne Team Leveraging our years of experience, world- class resources, and extensive product portfolio, we have built an organization with unparalleled expertise across a variety of life science fields and therapeutic areas. Through collaboration and constant innovation, we strive to make leading-edge products of the highest quality and dependability, and build assays and instruments that are the benchmark against which others are measured. Bio-Techne also offers custom prod- uct solutions when the exact item you need may not be currently available. Our scientists work closely with your team to find the best solutions in a timely and cost-effective way. We manage the technical risk, and ensure a stable, scalable, and consistent supply for future work. A Global Company Our offices and distribution centers stretch across the globe, and are vibrant commercial op- erations that exceed the expectations of our cus- tomers. With Bio-Techne, researchers can access all our brand offerings and technical support from a single source. We are committed to offer- ing innovative products of the highest quality to the research and diagnostic communities. As a company, Bio-Techne is committed to providing the best discovery tools needed to advance the life sciences, and support clinical breakthroughs in the treatment of human disease. *Luminex is a registered trademark of the Luminex Corporation. Creating Opportunities Through Innovation Samples and buffer are loaded directly into the cartridge. Cartridge contains glass nano reactors (GNRs). Inside the Cartridge Buffer Sample Fluor dAb-1 dAb-2 dAb-3 dAb-4 A single-plex immunoassay occurs in each channel. Sample is split across 4 parallel, isolated microfluidic channels